Author
Listed:
- Laetitia Keller
(UMR 1260, Regenerative Nanomedicine (RNM), FMTS
Hôpitaux Universitaires de Strasbourg)
- Luc Pijnenburg
(UMR 1260, Regenerative Nanomedicine (RNM), FMTS
Hôpitaux Universitaires de Strasbourg)
- Ysia Idoux-Gillet
(UMR 1260, Regenerative Nanomedicine (RNM), FMTS
Hôpitaux Universitaires de Strasbourg)
- Fabien Bornert
(UMR 1260, Regenerative Nanomedicine (RNM), FMTS
Hôpitaux Universitaires de Strasbourg)
- Laila Benameur
(McGill University)
- Maryam Tabrizian
(McGill University
McGill University)
- Pierrick Auvray
(Parc Technopolitain - Atalante Saint-Malo)
- Philippe Rosset
(Université François Rabeleis)
- Rosa María Gonzalo-Daganzo
(Hospital Universitario Puerta de Hierro Majadahonda)
- Enrique Gómez Barrena
(Hospital La Paz-IdiPAZ and Universidad Autónoma de Madrid)
- Luca Gentile
(UMR 1260, Regenerative Nanomedicine (RNM), FMTS
Hôpitaux Universitaires de Strasbourg
Hasselt University, Campus Diepenbeek, Agoralaan, Gebouw D
University of Applied Sciences, Kaiserslauter, Campus Zweibrücken)
- Nadia Benkirane-Jessel
(UMR 1260, Regenerative Nanomedicine (RNM), FMTS
Hôpitaux Universitaires de Strasbourg)
Abstract
The extended life expectancy and the raise of accidental trauma call for an increase of osteoarticular surgical procedures. Arthroplasty, the main clinical option to treat osteoarticular lesions, has limitations and drawbacks. In this manuscript, we test the preclinical safety of the innovative implant ARTiCAR for the treatment of osteoarticular lesions. Thanks to the combination of two advanced therapy medicinal products, a polymeric nanofibrous bone wound dressing and bone marrow-derived mesenchymal stem cells, the ARTiCAR promotes both subchondral bone and cartilage regeneration. In this work, the ARTiCAR shows 1) the feasibility in treating osteochondral defects in a large animal model, 2) the possibility to monitor non-invasively the healing process and 3) the overall safety in two animal models under GLP preclinical standards. Our data indicate the preclinical safety of ARTiCAR according to the international regulatory guidelines; the ARTiCAR could therefore undergo phase I clinical trial.
Suggested Citation
Laetitia Keller & Luc Pijnenburg & Ysia Idoux-Gillet & Fabien Bornert & Laila Benameur & Maryam Tabrizian & Pierrick Auvray & Philippe Rosset & Rosa María Gonzalo-Daganzo & Enrique Gómez Barrena & Luc, 2019.
"Preclinical safety study of a combined therapeutic bone wound dressing for osteoarticular regeneration,"
Nature Communications, Nature, vol. 10(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10165-5
DOI: 10.1038/s41467-019-10165-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10165-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.